December 2025

GLP-1 medications have transformed weight-loss treatment, helping millions of people reduce body weight more effectively than diet changes alone. However, growing evidence suggests that

  Americans looking for prescription support in managing obesity now have a new alternative to injections. Wegovy, long known as a once-weekly shot, is

U.S. health regulators have informed executives at Merck, Sanofi, and AstraZeneca that their infant respiratory syncytial virus (RSV) preventive therapies will undergo a new

  Millions of children across Australia have suddenly lost access to popular social media platforms due to a pioneering law aimed at shielding users

  Ukrainian President Volodymyr Zelensky said this week that the country could organize national elections within the next 60 to 90 days—but only if

  A newly organized alliance of political action committees promoting artificial intelligence has unveiled its first round of candidate ads for the 2026 midterm

  Across the United States, public frustration with the economy remains one of the most influential political forces shaping voter sentiment. Poll after poll

  As the competition for control of Warner Bros. intensifies, a surprising wildcard has emerged at the center of the corporate chaos: President Trump.

  A new financial program is on the horizon for American children born between 2025 and 2028 — the government’s so-called “Trump Account.” Each

  Apple, long admired for its consistent product vision and polished design philosophy, is now undergoing one of its most noticeable periods of transition